Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short term Debt (2016 - 2023)

Marimed has reported Short term Debt over the past 9 years, most recently at $3.6 million for Q3 2023.

  • Quarterly Short term Debt changed N/A to $3.6 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Sep 2023, changed N/A year-over-year, with the annual reading at $1.2 million for FY2020, 20.41% down from the prior year.
  • Short term Debt was $3.6 million for Q3 2023 at Marimed, roughly flat from $3.6 million in the prior quarter.
  • Over five years, Short term Debt peaked at $3.6 million in Q2 2023 and troughed at $77157.0 in Q2 2019.
  • The 3-year median for Short term Debt is $1.2 million (2020), against an average of $1.6 million.
  • Year-over-year, Short term Debt crashed 62.36% in 2019 and then soared 1703.22% in 2020.
  • A 3-year view of Short term Debt shows it stood at $1.5 million in 2019, then fell by 20.41% to $1.2 million in 2020, then skyrocketed by 210.93% to $3.6 million in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Short term Debt are $3.6 million (Q3 2023), $3.6 million (Q2 2023), and $3.3 million (Q1 2023).